Actively Recruiting
Prospective Observational Trial to Evaluate Quality of Life After Definitive Chemoradiation in Patients With Anal Cancer (LANACARE)
Led by Ludwig-Maximilians - University of Munich · Updated on 2019-01-03
100
Participants Needed
1
Research Sites
417 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Observational study to evaluate longitudinal quality of life according to standardized EORTC questionaires as well as functional outcome, oncological outcome and toxicity in patients treated with definitive chemoradiation for anal cancer
CONDITIONS
Official Title
Prospective Observational Trial to Evaluate Quality of Life After Definitive Chemoradiation in Patients With Anal Cancer (LANACARE)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histologically confirmed anal cancer without distant metastases
- Indication for definitive chemoradiation therapy based on multidisciplinary evaluation
- Age 18 years or older
- Written informed consent provided
- Ability to complete standardized questionnaires as determined by the treating physician
You will not qualify if you...
- Age under 18 years
- Prior systemic therapy for anal cancer
- Presence of distant metastases
- Second malignancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Radiation Oncology, University Hospital, LMU Munich
Munich, Bavaria, Germany, 81377
Actively Recruiting
Research Team
F
Falk Roeder, MD
CONTACT
S
Sabine Gerum, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here